肝癌细胞转移与PI3K-Akt-PAK1通路的相关性研究

doi:10.3969/j.issn.1672-5069.2017.03.013

摘要/Abstract

摘要： 目的研究肝细胞癌（HCC）组织PI3K/Akt/ p21活化蛋白激酶1（PAK1）信号通路的表达对于HCC发生及转移的重要性,以期为HCC的预防和预后提供一个有效的分子标志,并为HCC的治疗提供一定的理论基础。方法自NCBI中GEO数据库中的GES364数据集提取数据,对PI3K/Akt/PAK1信号通路基因的表达量进行分析。结果将数据库中HCC组织分为肝内扩散组（PS）、肝外转移组（PM）、无转移组（PN）和正常肝对照组（H）。分析发现PS组和PM组PAK1和MMP-9表达量明显高于H组和PN组（P<0.0001）;PS组、PM组和PN组AKT（1/2）和Girdin表达量明显高于H组（P<0.05）,PS组和PM组AKT2和Girdin表达量也明显高于PN组（P<0.05）;在PM组,AKT2与PAK1表达呈正相关（r=0.5679,P=0.0013）。结论 PAK1和MMP-9高表达可以促进HCC的扩散和转移,而AKT的表达和活性对于HCC的转移也是至关重要的,提示PI3K/AKT/PAK1信号通路与HCC转移密切相关。

关键词: 肝细胞癌, 转移, PAK1, AKT

Abstract: Objective Based on relevant database data,we tried to explore the importance of PI3K/Akt/PAK1 signaling pathway to HCC metastasis and provide an effective molecular marker for the prevention of HCC. Methods From GES364 data sets of GEO in the NCBI database,we searched the materials about the PI3K/Akt/PAK1 expression in intrahepatic spread （IHS）,entrahepatic metastasis （EHM）,non-metastasis （NM） and normal livers （N）. Results The expression of PAK1 and MMP-9 were up-regulated in IHS and EHM group（P<0.0001） as compared with those in normal liver and NM group; the expression of AKT （1/2） and Girdin were up-regulated in the IHS,EHM and NM group（P<0.05） as compared with in normal liver;in the EHM group,the expression of AKT2 was positively correlated to PAKI（r=0.5679,P=0.0013）. Conclusions The up-regulation of PAK1 and MMP-9 could promote the spread and metastasis of HCC cells,the increased expression and activities of AKT are crucial for metastasis of liver cancer,and the PI3K/AKT/PAK1 signaling pathway is closely related to the development and metastasis in patients with HCC.

Key words: Hepatocellular carcinoma, Metastasis, PAK1, AKT

张雷, 王林, 耿智敏, 万永, 孟凡迪, 孟宪魁. 肝癌细胞转移与PI3K-Akt-PAK1通路的相关性研究[J]. 实用肝脏病杂志, 2017, 20(3): 307-311.

Zhang Lei, Wang Lin, Geng Zhimin, et al.. Expression of PI3K-Akt-PAK1 pathway in the process of metastasis of hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 307-311.

参考文献

[1] Llovet JM,Burroughs A,Bruix J.Hepatocellular carcinoma. Lancet,2003,362:1907.
[2] Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002. CA Cancer J Clin,2005,55:74.
[3] Chen CJ,Yu MW,Liaw YF.Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol,1997,12:S294.
[4] Thorgeirsson SS,Grisham JW.Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet,2002,31:339.
[5] Bruix J,Boix L,Sala M,et al.Focus on hepatocellular carcinoma. Cancer Cell,2004,5:215.
[6] Laurent-Puig P,Legoix P,Bluteau O,et al.Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology,2001,120:1763.
[7] Wang XM,Yang LY,Guo L,et al.p53-induced RINGH2 protein,a novel marker for poor survival in hepatocellular carcinoma after hepatic resection. Cancer,2009,115:4554.
[8] Lau WY,Lai EC.Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int,2008,7:237.
[9] Manser E,Leung T,Salihuddin H,et al.A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature,1994,367:40.
[10] Knaus UG,Morris S,Dong HJ,et al.Regulation of human leukocyte p21-activated kinases through G proteinecoupled receptors. Science,1995,269:221.
[11] Martin GA,Bollag G,McCormick F,et al. A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20. EMBO J,1995,14:1970.
[12] Bagrodia S,Taylor SJ,Jordon KA,et al.A novel regulator of p21-activated kinases. J Biol Chem,1998,273:23633.
[13] Kumar R,Vadlamudi RK.Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol,2002,193:133.
[14] Bokoch GM.Biology of the p21-activated kinases. Annu Rev Biochem,2003,72:743.
[15] Hofmann C,Shepelev M,Chernoff J.The genetics of Pak. J Cell Sci,2004,117:4343.
[16] Kumar R,Gururaj AE,Barnes CJ. p21-activated kinases in cancer. Nat Rev Cancer,2006,6:459.
[17] Wells CM,Jones GE.The emerging importance of group II PAKs. Biochem J,2010,425:465.
[18] Jaffer ZM,Chernoff J. p21-activated kinases:three more join the Pak. Int J Biochem Cell Biol,2002,34:713.
[19] Zhao ZS,Manser E.PAK and other Rho-associated kinaseseeffectors with surprisingly diverse mechanisms of regulation. Biochem J,2005,386:201.
[20] Arias-Romero LE,Chernoff J.A tale of two Paks. Biol Cell,2008,100:97.
[21] Carter JH,Douglass LE,Deddens JA,et al.Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res,2004,10:3448.
[22] Bekri S,Adelaide J,Merscher S,et al.Detailed map of a region commonly amplified at 11q13>q14 in human breast carcinoma. Cytogenet Cell Genet,1997,79:125.
[23] Siu MK,Wong ES,Chan HY,et al.Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer:effects on prognosis and cell invasion. Int J Cancer,2010,127:21.
[24] Ching YP,Leong VY,Lee MF,et al.P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation. Cancer Res,2007,67:3601.
[25] Vadlamudi RK,Adam L,Wang RA,et al.Regulatable expression of p21-activated kinase-1 promotes anchorageindependent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem,2000,275:36238.
[26] Adam L,Vadlamudi R,Mandal M,et al.Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. J Biol Chem,2000,275:12041.
[27] Engelman JA,Luo J,Cantley LC.The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet,2006,7(8):606-619.
[28] Bellacosa A,Kumar CC,Cristofano AD,et al.Activation of AKT kinases in cancer:implications for therapeutic targeting. Adv Cancer Res,2005,94:29-86.
[29] Iyer SC,Gopal A,Halagowder D.Myricetin induces apoptosis by inhibiting P21 activated kinase 1(PAK1) signaling cascade in hepatocellular carcinoma. Mol Cell Biochem,2015,407(1-2):223-237.
[30] Li YY,Li J,Chen L.Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma. Tumour Biol,2014,35(4):3809-3817.
[31] Huynh N,Kevin HL,Baldwin GS,et al.P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK-and AKT-dependent pathways. Biochim Biophys Acta,2010,1803:1106-1113.
[32] Balmanno K,Chell SD,Gillings AS,et al.Intrinsic resistance to the MEK1/2 inhibitorAZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines. Int J Cancer,2009,125:2332-2341.